NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Prognostic gene expression signatures can be measured in tissues collected in RNAlater preservative.

Author(s): Chowdary D, Lathrop J, Skelton J, Curtin K, Briggs T, Zhang Y, Yu J, Wang Y, Mazumder A

Publication: J Mol Diagn, 2006, Vol. 8, Page 31-9

PubMed ID: 16436632 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to compare gene expression analysis by microarray of snap-frozen and RNA-later preserved breast and colon tumors.

Conclusion of Paper

Comparison of snap-frozen and RNAlater preserved tissues by microarray analysis showed a median Pearson's coefficient of 0.96-0.98, a 1:1 hybridization intensity, generally adjacent hierarchical clustering, and a 95-97% agreement in prediction of recurrence.

Studies

  1. Study Purpose

    The purpose of this study was to compare gene expression analysis by microarray of snap-frozen and RNA-later preserved breast and colon tumors.

    Summary of Findings:

    No significant differences in RNA yield or integrity were found between snap-frozen and RNAlater-preserved breast and colon specimens. The Pearson's correlation coefficient of snap-frozen and RNAlater-preserved specimens was 0.98 for breast tumors and 0.96 for colon tumors. After mutiple testing and correction for false discovery, a comparison of expression of snap-frozen and RNAlater-preserved specimens identified only 2 genes to be differentially expressed between preservation methods in breast tumors and no genes significantly different in colon tumors. Further, the ratio of the hybridization signal from snap-frozen and RNAlater-preserved specimens for each gene was found to be close to 1 and hierarchical clustering could not distinguish between the two preservation methods. When breast tissue was compared with colon tissue, 70% of the genes found to be up-or down regulated between tissue types were identified in both snap-frozen and RNAlater preserved tissues. Finally, the prediction of recurrence was similar between frozen and RNAlater-preserved tissues with 97% agreement for breast tumors and 95% agreement for colon tumors. In conclusion, RNAlater may be used for preservation of tissue specimens for microarray analysis.

    Biospecimens
    Preservative Types
    • RNAlater
    • Frozen
    Diagnoses:
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    RNA Spectrophotometry
    RNA Automated electrophoresis/Bioanalyzer
    RNA DNA microarray
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Preservation Type of fixation/preservation RNAlater
    Snap frozen
    Biospecimen Acquisition Biospecimen location Breast
    Colon

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...